https://www.selleckchem.com/pr....oducts/iclepertin.ht
6%. Among patients with persistent AF, survival free from recurrence at 1 year ranged from 24.9% to 60.0% (6 min and 7 consecutive days  23 h thresholds, respectively) with an overall median percentage of time in AF reduction of 99.3%. A single 7-day monitoring strategy had a sensitivity of less than 50% for detecting AF greater than 6 min in patients with paroxysmal and persistent AF. In this real-world data set of AF patients with CIEDs undergoing catheter ablation, treatment success varied substantially with different defi